Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145390 · ClinicalTrials.gov registry record · NA
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02145390 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 1 participants.
The verdict
NCT02145390, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Bladder preservation in patients with complete response after neoadjuvant chemotherapy will lead to equivalent or superior relapse free rates compared to cystectomy rates from historical controls.
Interventions
- RADIATION Intensity Modulated Radiation Therapy
- PROCEDURE Transurethral Resection of the Bladder Tumor & Cystoscopy
- BEHAVIORAL Expanded Prostate Cancer Index Composite Short Form 12
- BEHAVIORAL International Prostate Symptom Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-01-05 |
| Est. Completion | 2017-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02145390
The ClinicalTrials.gov registry entry for NCT02145390 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Intensity Modulated Radiation Therapy is the first listed.
NCT02145390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02145390 about?
NCT02145390 is a clinical study titled "Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy". Bladder preservation in patients with complete response after neoadjuvant chemotherapy will lead to equivalent or superior relapse free rates compared to cystectomy rates from historical controls.
What is the current status of trial NCT02145390?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-01-05. Estimated completion is 2017-04-25.
What interventions are being tested in trial NCT02145390?
The interventions under investigation include: Intensity Modulated Radiation Therapy (RADIATION), Transurethral Resection of the Bladder Tumor & Cystoscopy (PROCEDURE), Expanded Prostate Cancer Index Composite Short Form 12 (BEHAVIORAL), International Prostate Symptom Score (BEHAVIORAL).
Who is sponsoring clinical trial NCT02145390?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.